Medable End-to-End (E2E)
Medable’s mission is to deliver effective therapies to patients faster with technologies that enable massive efficiency and bring next generation intelligence to clinical research and patient care.
Go from the world of legacy technologies to E2E with Medable. Our end-to-end cloud platform provides a fully integrated suite of tools for clinical trials, removing silos and enabling Patients, Sites, CROs, and Sponsors to function as a trial team.
ACCESS & ENABLE
ANALYSIS AND ALGORITHMS
Every protocol is unique. Medable provides a suite of modular digital tools configured to meet the needs of each study and break down traditional barriers such as poor study access, ineffective screening, limited participation, and site inefficiency. The ultimate digital solution is rapidly configured and deployed to enable exponential improvements in trial execution.
Medable’s unique product architecture means that making a single initial investment begins to build a foundation of data and proprietary libraries for your organization. As more trial teams start to use Medable, this foundation grows exponentially stronger with data aggregation and sharing, real-time analytics and organization-wide survey and instrument libraries.
Medable’s technology is currently being used by over 750,000 patients across 5 continents. We are the only enterprise cloud purpose built for life sciences with dedicated AI and machine learning. We have experience with registry studies and Phase I-IV clinical trials as well as in the following areas and more.